PACS Group (NYSE:PACS) Research Coverage Started at Oppenheimer

Oppenheimer began coverage on shares of PACS Group (NYSE:PACS) in a research report sent to investors on Monday, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $31.00 price objective on the stock.

A number of other equities analysts have also recently issued reports on the company. Royal Bank of Canada initiated coverage on PACS Group in a report on Monday. They set an outperform rating and a $30.00 target price for the company. Truist Financial began coverage on PACS Group in a report on Monday. They set a buy rating and a $32.00 price objective for the company. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of Buy and a consensus price target of $30.50.

PACS Group Trading Down 1.3 %

Shares of PACS stock opened at $24.67 on Monday. PACS Group has a 12-month low of $22.61 and a 12-month high of $25.72.

Insider Activity

In other PACS Group news, CEO Jason Hulse Murray sold 1,607,142 shares of the business’s stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $21.00, for a total transaction of $33,749,982.00. Following the transaction, the chief executive officer now owns 62,754,551 shares of the company’s stock, valued at approximately $1,317,845,571. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.